ATE14979T1 - Zusammensetzung mit geregelter wirkstofffreigabe und verfahren zu ihrer herstellung. - Google Patents

Zusammensetzung mit geregelter wirkstofffreigabe und verfahren zu ihrer herstellung.

Info

Publication number
ATE14979T1
ATE14979T1 AT80300900T AT80300900T ATE14979T1 AT E14979 T1 ATE14979 T1 AT E14979T1 AT 80300900 T AT80300900 T AT 80300900T AT 80300900 T AT80300900 T AT 80300900T AT E14979 T1 ATE14979 T1 AT E14979T1
Authority
AT
Austria
Prior art keywords
controlled release
release composition
production
prostaglandin
residues
Prior art date
Application number
AT80300900T
Other languages
English (en)
Inventor
Mostyn Powell Embrey
Neil Bonnette Graham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Application granted granted Critical
Publication of ATE14979T1 publication Critical patent/ATE14979T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4833Polyethers containing oxyethylene units
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/65Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
    • C08G18/66Compounds of groups C08G18/42, C08G18/48, or C08G18/52
    • C08G18/6666Compounds of group C08G18/48 or C08G18/52
    • C08G18/667Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38
    • C08G18/6674Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3203
    • C08G18/6677Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3203 having at least three hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2210/00Compositions for preparing hydrogels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2250/00Compositions for preparing crystalline polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Lubricants (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fluid-Damping Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT80300900T 1979-03-21 1980-03-21 Zusammensetzung mit geregelter wirkstofffreigabe und verfahren zu ihrer herstellung. ATE14979T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7909853 1979-03-21
EP80300900A EP0016652B1 (de) 1979-03-21 1980-03-21 Zusammensetzung mit geregelter Wirkstofffreigabe und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE14979T1 true ATE14979T1 (de) 1985-09-15

Family

ID=10504015

Family Applications (2)

Application Number Title Priority Date Filing Date
AT80300900T ATE14979T1 (de) 1979-03-21 1980-03-21 Zusammensetzung mit geregelter wirkstofffreigabe und verfahren zu ihrer herstellung.
AT80300904T ATE15444T1 (de) 1979-03-21 1980-03-21 Zusammensetzung zur geregelten freigabe eines prostaglandins und verfahren zu ihrer herstellung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT80300904T ATE15444T1 (de) 1979-03-21 1980-03-21 Zusammensetzung zur geregelten freigabe eines prostaglandins und verfahren zu ihrer herstellung.

Country Status (11)

Country Link
US (2) US4931288A (de)
EP (2) EP0016652B1 (de)
JP (2) JPH0323529B2 (de)
AT (2) ATE14979T1 (de)
AU (2) AU537741B2 (de)
DE (2) DE3071006D1 (de)
GB (2) GB2047094B (de)
HK (2) HK79885A (de)
NZ (2) NZ193222A (de)
WO (2) WO1980001985A1 (de)
ZA (2) ZA801654B (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079009A (en) * 1979-03-21 1992-01-07 National Research Development Corporation Controlled release compositions including polyethylene oxide with urethane cross-linking
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
US4466936A (en) * 1981-02-03 1984-08-21 Bayer Aktiengesellschaft Production of molds using gel compositions with depot action based on a polyurethane matrix and relatively high molecular weight polyols
AU558611B2 (en) * 1981-02-03 1987-02-05 Bayer Aktiengesellschaft Polyurethane gel
DK171937B1 (da) * 1981-06-12 1997-08-18 British Tech Group Fremgangsmåde til fremstilling af partikelformige hydrogeler
DK260782A (da) * 1981-06-12 1982-12-13 Nat Res Dev Hydrogeler
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2539135B1 (fr) * 1983-01-11 1986-02-28 Essilor Int Hydrogels de polyurethane et procede de fabrication
GB2135881B (en) * 1983-03-02 1986-09-17 Erba Farmitalia Pharmaceutical compositions for inhibiting or reducing gastrointestinal side effects of non-steroidal anti-inflammatory drugs
DE3476550D1 (en) * 1983-07-21 1989-03-09 Troponwerke Gmbh & Co Kg Thermoplastics containing antiphlogistics
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
IL72041A (en) * 1984-06-05 1990-01-18 Elka Touitou Preparation for controlled release of iodine
US5439966A (en) * 1984-07-12 1995-08-08 National Research Development Corporation Polyethylene oxide temperature - or fluid-sensitive shape memory device
FR2582944B1 (fr) * 1985-06-11 1990-10-26 Commissariat Energie Atomique Piece en polymere, notamment en polyurethane de polyoxyethylene a gonflement anisotrope, son procede de fabrication et son utilisation comme dilatateur du col uterin
EP0347145A3 (de) * 1988-06-14 1990-10-24 University Of Utah Research Foundation Heterogene interpenetrierende Polymernetzwerke zur gesteuerten Arzneistofffreisetzung
US5342624A (en) * 1989-02-16 1994-08-30 British Technology Group Ltd. Dispensing device
EP0398472B1 (de) * 1989-03-17 1994-11-30 Ono Pharmaceutical Co., Ltd. Biologisch abbaubare Polyurethane
US5225514A (en) * 1989-03-17 1993-07-06 Ono Pharmaceutical Co., Ltd. Azo containing polyurethanes for drug delivery to the large intestines
GB8918589D0 (en) * 1989-08-15 1989-09-27 Graham Neil B Polymeric compositions
US5833665A (en) * 1990-06-14 1998-11-10 Integra Lifesciences I, Ltd. Polyurethane-biopolymer composite
JPH06502391A (ja) * 1990-07-26 1994-03-17 ジー.ディー.サール アンド カンパニー ポリマー性薬剤送達システム
WO1992011844A1 (en) * 1991-01-03 1992-07-23 Alkermes Controlled Therapeutics, Inc. Stabilization of proteins by cationic biopolymers
GB2254002B (en) * 1991-01-16 1995-03-22 Controlled Therapeutics Retrievable pessary
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
US5273742A (en) * 1991-12-30 1993-12-28 Tyndale Plains-Hunter Ltd. Biomedical water soluble hydrophilic polyurethane polymers and method of use thereof
GB9313017D0 (en) * 1993-06-24 1993-08-11 Univ Strathclyde Measurement of water content
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US6322815B1 (en) 1994-07-22 2001-11-27 W. Mark Saltzman Multipart drug delivery system
GB9418483D0 (en) * 1994-09-14 1994-11-02 British Tech Group Compound for use in pre-term labour
GB2295316B (en) * 1994-11-25 1997-09-10 William Leslie Porter Bolus for supplying biologically beneficial substances to ruminant animals
GB9506946D0 (en) * 1995-04-04 1995-05-24 Univ Strathclyde Microgels
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US6258351B1 (en) 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
DE19734538C1 (de) * 1997-07-30 1998-12-24 Jenapharm Gmbh Bioadhäsive Tablette
JP3786832B2 (ja) * 1998-01-07 2006-06-14 デビオ ルシェルシュ ファルマシュティーク ソシエテ アノニム 分解性のヘテロ二官能性ポリ(エチレングリコール)アクリレート及びそれから誘導されるゲル及び複合体
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
GB9826192D0 (en) 1998-12-01 1999-01-20 Controlled Theraputics Scotlan Oral transmucosal delivery
TWI246524B (en) * 2001-01-19 2006-01-01 Shearwater Corp Multi-arm block copolymers as drug delivery vehicles
US7265186B2 (en) * 2001-01-19 2007-09-04 Nektar Therapeutics Al, Corporation Multi-arm block copolymers as drug delivery vehicles
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
DE60322111D1 (de) 2002-12-31 2008-08-21 Nektar Therapeutics Al Co Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen
JP4758342B2 (ja) 2003-06-03 2011-08-24 キャンティマー インコーポレイテッド 相変化センサー
US20040259744A1 (en) * 2003-12-19 2004-12-23 Meidong Yang Skin and hair cleansers containing sulfur
ES2299776T3 (es) * 2004-06-16 2008-06-01 Straumann Holding Ag Membrana de barrera.
US7282584B2 (en) * 2004-06-16 2007-10-16 Straumann Holding Ag Methylene blue
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006133048A2 (en) * 2005-06-03 2006-12-14 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
EP2412744B1 (de) * 2005-07-18 2014-01-22 Nektar Therapeutics Verfahren zur Herstellung von verzweigten funktionalisierten Polymeren mithilfe von verzweigten Polyol-Kernen
DE102005053066A1 (de) * 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
CN101325976A (zh) * 2005-12-09 2008-12-17 巴斯夫欧洲公司 聚乙烯基内酰胺-聚氧化烯嵌段共聚物作为微水溶性化合物的加溶剂的用途
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP2037938A2 (de) * 2006-07-12 2009-03-25 Controlled Therapeutics (Scotland) Ltd. Arzneiabgabe-polymer mit clindamycin-hydrochloridsalz
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2173781A1 (de) * 2007-07-26 2010-04-14 Basf Se Verfahren zur herstellung von durch pfropfpolymerisation in lösung erhaltenen copolymeren auf basis von polyethern in fester form
EP2244782A4 (de) 2008-01-25 2011-09-14 Univ Utah Res Found Polymer für lineare freisetzung
DE102009052948B4 (de) * 2009-11-12 2013-05-29 Rkw Se Silageabdeckung
CA2834212C (en) 2011-04-29 2019-05-14 Massachusetts Institute Of Technology Layer processing for pharmaceuticals
GB201110601D0 (en) 2011-06-23 2011-08-03 Controlled Therapeutics Scotland Ltd Improved bioresorbable
US20150174139A1 (en) 2012-07-26 2015-06-25 Ferring B.V. Misoprostol Composition
EP2689781A1 (de) 2012-07-26 2014-01-29 Ferring B.V. Misoprostolzusammensetzung
KR20150034796A (ko) 2012-07-26 2015-04-03 훼링 비.브이. 미소프로스톨 제형
EP2689802A1 (de) 2012-07-26 2014-01-29 Ferring B.V. Misoprostolformulierung
EP2754443A1 (de) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol zur Geburtseinleitung
EP2754442A1 (de) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol zur Geburtseinleitung
US10213960B2 (en) 2014-05-20 2019-02-26 Massachusetts Institute Of Technology Plasticity induced bonding
GB201916808D0 (en) 2019-11-19 2020-01-01 Ferring Bv Pharmaceutical delivery device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1050353B (it) * 1966-01-06 1981-03-10 Ceskoslovenska Akademie Ved Supporti per sostanze biologigamente attive
US3822238A (en) * 1972-08-02 1974-07-02 Princeton Polymer Lab Hydrophilic polyurethane polymers
US3975350A (en) * 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US3953406A (en) * 1973-01-26 1976-04-27 California Institute Of Technology Water-insoluble, swellable polyurethanes
US3993551A (en) * 1973-09-10 1976-11-23 Union Carbide Corporation Process for cocrosslinking water soluble polymers and products thereof
FR2250793B1 (de) * 1973-11-09 1978-12-29 Commissariat Energie Atomique
GB1494814A (en) * 1976-07-14 1977-12-14 Sanyo Chemical Ind Ltd Agrochemical compositions
GB1551620A (en) * 1976-12-13 1979-08-30 Ici Ltd Delivery means for biologically active agents
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat

Also Published As

Publication number Publication date
WO1980001985A1 (en) 1980-10-02
JPS56500254A (de) 1981-03-05
NZ193221A (en) 1984-08-24
GB2047093A (en) 1980-11-26
DE3071070D1 (en) 1985-10-17
GB2047094A (en) 1980-11-26
EP0016652A1 (de) 1980-10-01
AU5669180A (en) 1980-09-25
JPH0323530B2 (de) 1991-03-29
JPH0323529B2 (de) 1991-03-29
GB2047093B (en) 1983-12-07
AU5669080A (en) 1980-09-25
EP0016652B1 (de) 1985-08-21
AU537740B2 (en) 1984-07-12
US4894238A (en) 1990-01-16
US4931288A (en) 1990-06-05
JPS56500253A (de) 1981-03-05
HK79785A (en) 1985-10-25
AU537741B2 (en) 1984-07-12
EP0016654A1 (de) 1980-10-01
GB2047094B (en) 1983-12-07
DE3071006D1 (en) 1985-09-26
NZ193222A (en) 1984-08-24
EP0016654B1 (de) 1985-09-11
ZA801659B (en) 1981-10-28
ZA801654B (en) 1981-10-28
ATE15444T1 (de) 1985-09-15
HK79885A (en) 1985-10-25
WO1980001984A1 (en) 1980-10-02

Similar Documents

Publication Publication Date Title
ATE14979T1 (de) Zusammensetzung mit geregelter wirkstofffreigabe und verfahren zu ihrer herstellung.
GB2066268B (en) Ethylene polymer composition
DE3885494D1 (de) Verfahren zur Herstellung von Propylenpolymergranulaten.
DE3787459D1 (de) Aminogruppenhaltige Polymerisate, ihre Herstellung und ihre Verwendung.
ATE7923T1 (de) Vinylpolymer mit acetylacetoxygruppen, verfahren zu seiner herstellung und daraus erhaltenes mittel.
BE886607A (fr) Composition a base d'un polysilane a groupes trimethylsiloxy, sa preparation et son utilisation
ATA314177A (de) Verfahren zur herstellung von neuen amino- und hydroxyl- bzw. mercaptogruppenhaltigen poly- meren
GB1548974A (en) Optical pcm group transmission repeating system
DE3786249D1 (de) Kugelfoermige korundkoerper, verfahren zu ihrer herstellung und sie enthaltende hochwaermeleitende gummi- und kunststoffzusammensetzungen.
ATE124708T1 (de) Vernetzte, poröse, hautlose teilchen aus pvc-harz und verfahren zu ihrer herstellung.
ATE54429T1 (de) Farbige kontaktlinsen und verfahren zu ihrer herstellung.
DE59105139D1 (de) Thermoplastische, flexible Polyurethan-Zusammensetzungen und Verfahren zu ihrer Herstellung.
AT373608B (de) Polymer/polyol-mischung als ausgangsprodukt fuer polyurethane und verfahren zu ihrer herstellung
ATE62917T1 (de) Polymere zusammensetzung, verfahren zu ihrer herstellung und thermoplastische polymere zusammensetzung.
ES2001644A6 (es) Procedimiento para la obtencion de poliesteres alifaticos conteniendo azufre y su empleo para la obtencion de polimeros sinteticos.
ATE67509T1 (de) Thiolgruppenhaltige polymere, verfahren zu ihrer herstellung und ihre verwendung.
JPS53110680A (en) Affording hydrophillic nature to molded product
DE2861323D1 (en) Melt processable wholly aromatic polyester composition containing a phosphorus ester, process for the preparation thereof, and moulded articles, films and fibres based thereon
DE3361052D1 (en) Process for preparing block copolymers based on ethylene polymers and other polymers
ATE3979T1 (de) Isocyanatgruppenhaltige 2,4,6triketohexahydrotriazine und ein verfahren zu ihrer herstellung.
DE3376005D1 (en) Process for the manufacture of block copolymers on the basis of polymerisates of ethylene and other polymers
ATE3539T1 (de) Halbester organischer polyole enthaltende zusammensetzungen, verfahren zu ihrer herstellung und verwendung dieser zusammensetzungen zur herstellung geformter artikel.
ATE10848T1 (de) Homo- und copolymere von 1,3-dienen mit reaktiven silylgruppen, verfahren zu ihrer herstellung sowie deren verwendung.
ATE93247T1 (de) Polythioharnstoffe, verfahren zu ihrer herstellung und verwendung dieser polythioharnstoffe zur verhinderung oder herabsetzung der krustenbildung von polymerisationsreaktoren.
ATE4899T1 (de) 2,4-diamino-5-sulfamoylbenzolsulfosaeuren und verfahren zu ihrer herstellung.